Molecular Imaging and Nuclear MedicineLateral ectopic thyroid mimics carotid body tumor on Indium-111 Pentetreotide (cas 138661-02-6) scintigraphy
-
Add time:09/04/2019 Source:sciencedirect.com
A 34-year old woman with past history of anxiety, depression, and hypothyroidism resulting from prior total thyroidectomy for multinodular goiter presented with complaints of palpitations, sweating, and tachycardia. Clinical examination revealed a painless right lateral neck mass. USG/CT of the neck revealed the soft tissue mass located at the right carotid bifurcation. A subsequent Indium-111 Pentetreotide (cas 138661-02-6) somatostatin receptor scintigraphy (SRS) demonstrated tracer uptake in the mass. Hence, secretory carotid body tumor/paraganglioma was strongly suspected. However, post-surgical histopathological specimen revealed only benign thyroid follicles indicative of lateral ectopic thyroid with no evidence of neuroendocrine cells or malignancy. This case highlights the importance of considering lateral ectopic thyroid, a very rare entity, in the differential diagnosis for carotid bifurcation masses. Also highlighted is the false positivity from normal but ectopic thyroid tissue on Indium-111 pentetreotide SRS mimicking a paraganglioma.
We also recommend Trading Suppliers and Manufacturers of Pentetreotide (cas 138661-02-6). Pls Click Website Link as below: cas 138661-02-6 suppliers
Prev:Microwave-assisted synthesis of 1,5-dioxo-3-substituted [5]ferrocenophanes
Next:Original articleValue of 111In-Pentetreotide (cas 138661-02-6) scintigraphy and 18F-FDG PET for clinical prognosis of patients with neuroendocrine neoplasmsValeur pronostique de la scintigraphie à l’111In-Pentetreotide (cas 138661-02-6) et la TEP au 18F-FDG chez des patients atteints de tumeur neuroendocrine) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- P_84111In-pentetréotide pour la détection de l’endométriose profonde : à propos d’un cas09/26/2019
- Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-Pentetreotide (cas 138661-02-6) in rats09/25/2019
- Indium-111-Pentetreotide (cas 138661-02-6) prolongs survival in gastroenteropancreatic malignancies*09/24/2019
- Case ReportRecurrent Pneumonia Due to Bronchial Carcinoid Tumour in a Young Patient: The Role of 111In-Pentetreotide (cas 138661-02-6) in Imaging StudiesTumor carcinoide bronquial como causa de neumonías de repetición en paciente joven: papel del 111In-pentetreotida en el contexto de las pruebas de imagen☆09/10/2019
- Sarcoidosis mimicking metastatic carinoid on indium-111 Pentetreotide (cas 138661-02-6) scintigraphy09/09/2019
- Original articleValidation of stationary phases in 111In-Pentetreotide (cas 138661-02-6) planar chromatographyValidación de fases estacionarias en la cromatografía planar de 111In-pentetreótida☆09/08/2019
- Original investigationIncremental Value of 111-In Pentetreotide (cas 138661-02-6) SPECT/CT Fusion Imaging of Neuroendocrine Tumors09/07/2019
- Notas clínicas111In-Pentetreotide (cas 138661-02-6) uptake in a follicular adenoma of the thyroid gland: a pitfall for 111In-Pentetreotide (cas 138661-02-6) scintigraphyCaptación de 111in-pentetreotida en un adenoma folicular de la glándula tiroides: falso positivo en la gammagrafía con 111in-pentetreotida09/06/2019
- Original articleValue of 111In-Pentetreotide (cas 138661-02-6) scintigraphy and 18F-FDG PET for clinical prognosis of patients with neuroendocrine neoplasmsValeur pronostique de la scintigraphie à l’111In-Pentetreotide (cas 138661-02-6) et la TEP au 18F-FDG chez des patients atteints de tumeur neuroendocrine09/05/2019


